Hillman Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04M Buy
55,700
+9,731
+21% +$893K 3.5% 7
2025
Q4
$4.13M Sell
45,969
-6,846
-13% -$649K 2.6% 17
2025
Q3
$5.2M Sell
52,815
-2,783
-5% -$276K 3.03% 15
2025
Q2
$5.07M Sell
55,598
-2,959
-5% -$286K 2.77% 18
2025
Q1
$6.63M Sell
58,557
-20,382
-26% -$2.18M 3.26% 4
2024
Q4
$8.34M Sell
78,939
-1,748
-2% -$188K 3.09% 11
2024
Q3
$8.71M Buy
80,687
+34,389
+74% +$3.75M 2.99% 11
2024
Q2
$5.02M Sell
46,298
-146
-0.3% -$17.2K 1.77% 37
2024
Q1
$6.13M Buy
46,444
+960
+2% +$120K 1.97% 35
2023
Q4
$5.54M Sell
45,484
-972
-2% -$108K 1.91% 33
2023
Q3
$5.21M Sell
46,456
-1,810
-4% -$230K 2.01% 33
2023
Q2
$7.03M Sell
48,266
-140
-0.3% -$19K 2.48% 21
2023
Q1
$6.25M Sell
48,406
-190
-0.4% -$23.9K 2.37% 26
2022
Q4
$6.2M Sell
48,596
-10,302
-17% -$1.2M 2.43% 21
2022
Q3
$6.16M Buy
58,898
+390
+0.7% +$42.8K 2.56% 20
2022
Q2
$6.15M Buy
58,508
+6,207
+12% +$736K 2.23% 30
2022
Q1
$6.69M Sell
52,301
-732
-1% -$88.2K 2.12% 34
2021
Q4
$6.54M Buy
53,033
+49,120
+1,255% +$6.43M 2.25% 29
2021
Q3
$556K Buy
+3,913
New +$576K 0.2% 41

Other funds holding ZBH

Hillman Capital Management's ZBH Position: Q1 2026 in Review

Hillman Capital Management increased its Zimmer Biomet (ZBH) stake by 21% in Q1 2026, buying an estimated $893K and bringing the position to 55,700 shares worth $5.04M. The position accounts for 3.5% of the portfolio, ranked #7.

Hillman Capital Management first reported a position in ZBH in Q3 2021 and has held it in 19 quarters since. The position peaked at $8.71M in Q3 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Hillman Capital Management held 55,700 shares of Zimmer Biomet worth $5.04M as of Q1 2026.
  • Hillman Capital Management bought 9,731 Zimmer Biomet shares in Q1 2026, an estimated $893K.
  • Zimmer Biomet made up 3.5% of Hillman Capital Management's portfolio in Q1 2026, its #7 holding.
  • Hillman Capital Management first reported a position in Zimmer Biomet in Q3 2021 and has held it in 19 quarters since.
  • Hillman Capital Management's Zimmer Biomet position peaked at $8.71M in Q3 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.